Tuesday, 14 September 2021

Study on Procalcitonin as a Prognostic Indicator and as an Early Biomarker in Grading of Sepsis| Chapter 7 | New Visions in Science and Technology Vol. 2

 The goal of this study was to look into the pattern of PCT rise in sepsis. To see if PCT rises earlier than other sepsis indicators in severe infections. To explore if PCT levels may be used to grade the severity of sepsis. To see if the rise and fall of PCT levels affects prognosis in any way. Introduction: PCT is an excellent sepsis biomarker. PCT (procalcitonin) is a novel biomarker that is being used all over the world to identify and evaluate bacterial sepsis. PCT helps with sepsis and septic shock prognosis by distinguishing between infectious and non-infectious illnesses. Materials and Procedures: A total of 100 individuals were enrolled in the trial, all of them were hospitalised to medical or surgical departments. The PCT, as well as other sepsis markers, were calculated and the findings compared. Clinical criteria and PCT levels were used to determine the severity of sepsis. PCT readings in the total sample correlated strongly with the degree of sepsis, with a median of 8.89 ng/ml. In 24 individuals, normal PCT levels were found, while four patients had extremely high PCT levels. PCT levels above 7 ng/ml have been associated to an increased risk of death. Gram negative sepsis had higher PCT values when compared to Gram positive sepsis. Consistently rising PCT levels indicated a higher degree of sepsis, as well as a significant mortality rate in this class. Conclusions: PCT is an early-detectable sepsis biomarker. PCT can be used as a prognostic indication in severe sepsis. PCT is a valuable tool for grading sepsis and other clinical features.



Author (S) Details

Chidanand G. Chivate
Department of Medicine, BVDUMC and Hospital, Sanglali, Maharashtra, India.

Gajanaan Belwalkar
Department of Biochemistry, BVDUMC and Hospital, Sanglali, Maharashtra, India.


Rahul V. Patil
Department of Medicine, BVDUMC and Hospital, Sanglali, Maharashtra, India.


Jayashree C. Awalekar

Department of Medicine, BVDUMC and Hospital, Sanglali, Maharashtra, India.

Shrinivas S. Kumbhar
Department of Medicine, BVDUMC and Hospital, Sanglali, Maharashtra, India.

Shubhaangi V. Deshmukh
Department of Medicine, BVDUMC and Hospital, Sanglali, Maharashtra, India.


View Book :- https://stm.bookpi.org/NVST-V2/article/view/3444

No comments:

Post a Comment